ECOVAXXIN® MS EU marketing authorisation granted

AI SummaryClose X

ECO Animal Health Group plc has received EU marketing authorisation for its poultry vaccine ECOVAXXIN® MS, which targets Mycoplasma synoviae infections and aims to reduce air-sac and foot-pad lesions and egg production losses, potentially impacting laying hens by 5-10%. This authorisation was granted over a month earlier than expected, following a positive opinion in November 2025, and represents the first commercial launch from the company's R&D portfolio. ECO Animal Health plans to provide further details on the EU commercial launch in early 2026.

Disclaimer*

UK 100

Latest directors dealings